Citation 1:
    Title: Merck Announces Fourth-Quarter 2024 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-2024-dividend/#:~:text=July%2023%2C%202024%2012%3A52%20pm,ET
    Location: chars 326–463

Citation 2:
    Title: Merck Announces First-Quarter 2025 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-first-quarter-2025-dividend/#:~:text=November%2019%2C%202024%2012%3A22%20pm,ET
    Location: chars 464–604

Citation 3:
    Title: Merck Shares Outstanding 2010-2025 | MRK | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/MRK/merck/shares-outstanding#:~:text=,increase%20from%202022
    Location: chars 625–752

Citation 4:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Total%20debt%20to%20total%20liabilities,0.6%3A1
    Location: chars 978–1133

Citation 5:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,%284%2C388%29
    Location: chars 1134–1294

Citation 6:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=%245,to%20%241.3%20billion%2C%20they
    Location: chars 1363–1556

Citation 7:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=Merck%20reported%20a%207,to%20%241.3%20billion%2C%20they
    Location: chars 1584–1797

Citation 8:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=met%20analyst%20projections,to%20%241.6%20billion
    Location: chars 1844–2050

Citation 9:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=met%20analyst%20projections,to%20%241.6%20billion
    Location: chars 2095–2301

Citation 10:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=%247,to%20%241.6%20billion
    Location: chars 2333–2516

Citation 11:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=For%20the%20year%202025%2C%20Merck,for%20boosting%20domestic%20pharmaceutical%20manufacturing
    Location: chars 2702–2952

Citation 12:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=%245,to%20%241.3%20billion%2C%20they
    Location: chars 3128–3321

Citation 13:
    Title: Merck pauses Gardasil shipments to China, hitting its 2025 outlook
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-pauses-gardasil-shipments-china-hitting-its-2025-outlook-2025-02-04/#:~:text=Merck%20announced%20a%20suspension%20of,in%20premarket%20trading.%20The
    Location: chars 3353–3588

Citation 14:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=,1%20Receptor%20Agonist
    Location: chars 3892–4038

Citation 15:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=,1%20Receptor%20Agonist
    Location: chars 4120–4266

Citation 16:
    Title: Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-buys-cancer-therapy-developer-modifi-biosciences-up-13-bln-2024-10-23/#:~:text=Merck%20has%20announced%20the%20acquisition,clinical%20cancer%20therapies%20designed%20to
    Location: chars 4377–4632

Citation 17:
    Title: Merck's colorectal cancer therapy fails late-stage trial
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-colorectal-cancer-therapy-fails-late-stage-trial-2024-09-25/#:~:text=Merck%20announced%20a%20setback%20as,Other%20ongoing
    Location: chars 4719–4928

Citation 18:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=For%20the%20year%202025%2C%20Merck,for%20boosting%20domestic%20pharmaceutical%20manufacturing
    Location: chars 5235–5485

Citation 19:
    Title: Merck pauses Gardasil shipments to China, hitting its 2025 outlook
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-pauses-gardasil-shipments-china-hitting-its-2025-outlook-2025-02-04/#:~:text=Merck%20announced%20a%20suspension%20of,in%20premarket%20trading.%20The
    Location: chars 5646–5881

Citation 20:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=,29
    Location: chars 6370–6496

Citation 21:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,%284%2C388%29
    Location: chars 7002–7162

Citation 22:
    Title: Merck Announces First-Quarter 2025 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-first-quarter-2025-dividend/#:~:text=November%2019%2C%202024%2012%3A22%20pm,ET
    Location: chars 7258–7398

Citation 23:
    Title: mrk-20240930
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/mrk-20240930.htm#:~:text=In%202018%2C%20Merck%E2%80%99s%20Board%20of,an%20exchange%2C%20or%20in%20privately
    Location: chars 7449–7639

Citation 24:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Total%20debt%20to%20total%20liabilities,0.6%3A1
    Location: chars 7721–7876

Citation 25:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Total%20debt%20to%20total%20liabilities,0.6%3A1
    Location: chars 8001–8156

Citation 26:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,%284%2C388%29
    Location: chars 8157–8317

Citation 27:
    Title: Merck plans to  launch US subcutaneous version of Keytruda on October 1
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-plans-us-launch-subcutaneous-version-keytruda-october-1-2025-03-27/#:~:text=Merck%20%26%20Co%20announced%20plans,The
    Location: chars 8538–8741

Citation 28:
    Title: Merck pauses Gardasil shipments to China, hitting its 2025 outlook
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-pauses-gardasil-shipments-china-hitting-its-2025-outlook-2025-02-04/#:~:text=Merck%20announced%20a%20suspension%20of,in%20premarket%20trading.%20The
    Location: chars 9008–9243

Citation 29:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Sales%20%20,N%2FM
    Location: chars 9522–9662

Citation 30:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Sales%20%20,N%2FM
    Location: chars 9693–9833

Citation 31:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Generally%20Accepted%20Accounting%20Principles%20,quarter%20of%202024%20include%20a
    Location: chars 9955–10161

Citation 32:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=,29
    Location: chars 10206–10332

Citation 33:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=%2A%20Full,Anticipated%20Milestone%20Payment%20to%20LaNova
    Location: chars 10467–10648

Citation 34:
    Title: Merck pauses Gardasil shipments to China, hitting its 2025 outlook
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-pauses-gardasil-shipments-china-hitting-its-2025-outlook-2025-02-04/#:~:text=Merck%20announced%20a%20suspension%20of,in%20premarket%20trading.%20The
    Location: chars 10721–10956

Citation 35:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=devaluation%20of%20Argentine%20peso%2C%20which,Decline%20primarily%20due%20to%20lower
    Location: chars 10998–11206

Citation 36:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=,1%20Receptor%20Agonist
    Location: chars 11521–11667

Citation 37:
    Title: Merck plans to  launch US subcutaneous version of Keytruda on October 1
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-plans-us-launch-subcutaneous-version-keytruda-october-1-2025-03-27/#:~:text=Merck%20%26%20Co%20announced%20plans,The
    Location: chars 11748–11951

Citation 38:
    Title: Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-buys-cancer-therapy-developer-modifi-biosciences-up-13-bln-2024-10-23/#:~:text=Merck%20has%20announced%20the%20acquisition,clinical%20cancer%20therapies%20designed%20to
    Location: chars 12180–12435

Citation 39:
    Title: Merck Announces First-Quarter 2025 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-first-quarter-2025-dividend/#:~:text=November%2019%2C%202024%2012%3A22%20pm,ET
    Location: chars 12649–12789

Citation 40:
    Title: Merck Announces Fourth-Quarter 2024 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-2024-dividend/#:~:text=July%2023%2C%202024%2012%3A52%20pm,ET
    Location: chars 12790–12927

Citation 41:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Adjustments%20to%20reconcile%20net%20income,1%2C824
    Location: chars 13766–13925

Citation 42:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=For%20the%20year%202025%2C%20Merck,for%20boosting%20domestic%20pharmaceutical%20manufacturing
    Location: chars 14186–14436

Citation 43:
    Title: Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2021-financial-results/#:~:text=%2A%20Full,Billion%3B%20Excluding%20the%20Impact%20From
    Location: chars 14765–14943

Citation 44:
    Title: Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2022-financial-results/#:~:text=%2A%20Full,Foreign%20Exchange%2C%20Sales%20Grew%2027
    Location: chars 14953–15128

Citation 45:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Sales%20%20,N%2FM
    Location: chars 15138–15278

Citation 46:
    Title: Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2024-financial-results/#:~:text=Sales%20%20,N%2FM
    Location: chars 15288–15428

Citation 47:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=%245,to%20%241.3%20billion%2C%20they
    Location: chars 15438–15631

Citation 48:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 15943–16072

Citation 49:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 17234–17363

Citation 50:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 17388–17517

Citation 51:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 17573–17702

Citation 52:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 17728–17857

Citation 53:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 17910–18039

Citation 54:
    Title: Pfizer PE Ratio 2010-2025 | PFE | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/PFE/pfizer/pe-ratio#:~:text=Eli%20Lilly%20%28LLY%29%20%20,0.00
    Location: chars 18064–18193

Citation 55:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=included%20in%20Other%20current%20assets,12%2C773
    Location: chars 18552–18709

Citation 56:
    Title: mrk-20240930
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/mrk-20240930.htm#:~:text=Loans%20payable%20and%20current%20portion,33%2C683
    Location: chars 18797–18955

Citation 57:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Total%20debt%20to%20total%20liabilities,0.6%3A1
    Location: chars 18999–19154

Citation 58:
    Title: mrk-20241231
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm#:~:text=Net%20Cash%20Provided%20by%20Operating,%284%2C388%29
    Location: chars 19193–19353

Citation 59:
    Title: mrk-20240930
    URL: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/mrk-20240930.htm#:~:text=In%202018%2C%20Merck%E2%80%99s%20Board%20of,an%20exchange%2C%20or%20in%20privately
    Location: chars 19609–19799

Citation 60:
    Title: Merck Announces First-Quarter 2025 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-first-quarter-2025-dividend/#:~:text=November%2019%2C%202024%2012%3A22%20pm,ET
    Location: chars 19962–20102

Citation 61:
    Title: Merck Announces Fourth-Quarter 2024 Dividend - Merck.com
    URL: https://www.merck.com/news/merck-announces-fourth-quarter-2024-dividend/#:~:text=July%2023%2C%202024%2012%3A52%20pm,ET
    Location: chars 20103–20240

Citation 62:
    Title: Merck Shares Outstanding 2010-2025 | MRK | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/MRK/merck/shares-outstanding#:~:text=,increase%20from%202022
    Location: chars 20513–20640

Citation 63:
    Title: Merck expects cancer therapy Keytruda to be part of government price setting in 2026
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-expects-cancer-therapy-keytruda-be-part-government-price-setting-2026-2025-02-25/#:~:text=Merck%20anticipates%20its%20leading%20cancer,for%20ten%20prescription%20drugs
    Location: chars 21299–21553

Citation 64:
    Title: Merck posts higher profit, puts tariffs cost at $200 million
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-profit-puts-tariffs-cost-200-million-2025-04-24/#:~:text=For%20the%20year%202025%2C%20Merck,for%20boosting%20domestic%20pharmaceutical%20manufacturing
    Location: chars 21829–22079

Citation 65:
    Title: Merck pauses Gardasil shipments to China, hitting its 2025 outlook
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/merck-pauses-gardasil-shipments-china-hitting-its-2025-outlook-2025-02-04/#:~:text=Merck%20announced%20a%20suspension%20of,in%20premarket%20trading.%20The
    Location: chars 22166–22401

Citation 66:
    Title: Merck's colorectal cancer therapy fails late-stage trial
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-colorectal-cancer-therapy-fails-late-stage-trial-2024-09-25/#:~:text=Merck%20announced%20a%20setback%20as,Other%20ongoing
    Location: chars 22640–22849

